scholarly journals Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells

2014 ◽  
Vol 9 (6) ◽  
pp. 2417-2422 ◽  
Author(s):  
MIN WU ◽  
YUAN YUAN ◽  
YUE-YIN PAN ◽  
YING ZHANG
Keyword(s):  
Lung Cancer ◽  
Antitumor Activity ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Combination Treatment ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
Egfr Tki

scholarly journals Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells

2017 ◽  
Vol 58 (3) ◽  
pp. 581
Author(s):  
Jun Pei ◽  
Tianqing Chu ◽  
Minhua Shao ◽  
Jiajun Teng ◽  
Huifang Sha ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Antitumor Activity ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
Potential Antitumor

Abstract 3081: SHOC2 is a critical modulator of the sensitivity to EGFR-TKI in non-small cell lung cancer cells

2020 ◽  
Author(s):  
Hideki Terai ◽  
Junko Hamamoto ◽  
Tadashi Manabe ◽  
Katsura Emoto ◽  
Takeshi Masuda ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
Egfr Tki

scholarly journals Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Hiroki Sato ◽  
Kazuhiko Shien ◽  
Shuta Tomida ◽  
Kazuhiro Okayasu ◽  
Ken Suzawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Cells ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Lung Cancer Cells ◽  
Small Cell Lung ◽  
Tki Resistance ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document